|
neuroprotection |
17 |
|
glaucoma |
15 |
|
bronchi - cytology |
12 |
|
conjunctiva - virology |
12 |
|
influenza a virus, h1n1 subtype - metabolism |
12 |
|
influenza, human - virology |
12 |
|
respiratory system - virology |
12 |
|
retinal ganglion cell |
9 |
|
animals |
8 |
|
apoptosis |
8 |
|
cornea |
8 |
|
endothelin-1 |
8 |
|
lycium barbarum polysaccharides |
8 |
|
retina |
8 |
|
animal model |
7 |
|
intraocular pressure |
7 |
|
mental health |
7 |
|
ocular perfusion |
7 |
|
physical exercise |
7 |
|
acute ocular hypertensive injury |
6 |
|
anti-inflammatory |
6 |
|
cellular neuroscience |
6 |
|
eye |
6 |
|
hippocampus |
6 |
|
mice |
6 |
|
molecular neuroscience |
6 |
|
nanoindentation |
6 |
|
neuroscience |
6 |
|
oxidative stress |
6 |
|
stroke |
6 |
|
transcorneal electrical stimulation |
6 |
|
3d culturing |
5 |
|
astrocyte |
5 |
|
astrocytes |
5 |
|
blood-brain barrier |
5 |
|
brain injury |
5 |
|
cell death |
5 |
|
fibroblasts |
5 |
|
gene deletion |
5 |
|
glia |
5 |
|
hypoxia |
5 |
|
ischemia |
5 |
|
ischemic stroke |
5 |
|
mice, inbred c57bl |
5 |
|
myofibroblasts |
5 |
|
stromal fibrosis |
5 |
|
transforming growth factor-beta 1 |
5 |
|
vision |
5 |
|
426 apoptosis/cell death |
4 |
|
530 ganglion cells |
4 |
|
685 retina |
4 |
|
aldehyde reductase - antagonists & inhibitors - deficiency - genetics - physiology |
4 |
|
aldehyde reductase - deficiency - genetics |
4 |
|
aldehyde reductase - deficiency - genetics - metabolism |
4 |
|
alginate |
4 |
|
alginates - pharmacology |
4 |
|
alzheimer's disease |
4 |
|
amyloidosis |
4 |
|
animals, newborn - metabolism |
4 |
|
antigens, cd31 - genetics |
4 |
|
apoptosis - drug effects |
4 |
|
apoptosis - physiology |
4 |
|
astrocytes - metabolism |
4 |
|
blood-brain barrier - drug effects |
4 |
|
blood-retinal barrier |
4 |
|
blood-retinal barrier - drug effects - physiopathology |
4 |
|
blood-retinal barrier - physiopathology |
4 |
|
blotting, western |
4 |
|
brain - cytology - metabolism |
4 |
|
brain chemistry |
4 |
|
brain chemistry - genetics - physiology |
4 |
|
brain edema - etiology - pathology - physiopathology - prevention and control |
4 |
|
brain ischemia - enzymology - metabolism - pathology |
4 |
|
brain slice |
4 |
|
cell death - physiology |
4 |
|
cell proliferation |
4 |
|
cerebral infarct |
4 |
|
cerebral ischemia |
4 |
|
collagen |
4 |
|
collagen - pharmacology |
4 |
|
corneal scarring |
4 |
|
cortex |
4 |
|
db/db mouse |
4 |
|
diabetes mellitus - genetics - physiopathology |
4 |
|
diabetes mellitus, type 2 - complications - enzymology - metabolism - pathology |
4 |
|
disease models, animal |
4 |
|
drug carriers |
4 |
|
drugs, chinese herbal - pharmacology |
4 |
|
drugs, chinese herbal - pharmacology - therapeutic use |
4 |
|
edema |
4 |
|
endothelin-1 - biosynthesis - genetics |
4 |
|
endothelium, vascular - cytology - metabolism |
4 |
|
fibroblast |
4 |
|
gdnf |
4 |
|
gene expression regulation, enzymologic |
4 |
|
glial cell |
4 |
|
glial cell line-derived neurotrophic factor - secretion |
4 |
|
glutamic acid - metabolism |
4 |
|
hek293 cells |
4 |
|
human keratocytes |
4 |
|
hypoxia-ischemia, brain - metabolism |
4 |
|
imidazolidines - therapeutic use |
4 |
|
immunohistochemistry |
4 |
|
l-iditol 2-dehydrogenase - antagonists & inhibitors - genetics - physiology |
4 |
|
lycium barbarum |
4 |
|
mice, mutant strains |
4 |
|
microencapsulation |
4 |
|
microglia |
4 |
|
microsphere |
4 |
|
microspheres |
4 |
|
mouse |
4 |
|
müller cells |
4 |
|
neurodegeneration |
4 |
|
neuroglia |
4 |
|
neuroglia - metabolism |
4 |
|
neuronal apoptosis |
4 |
|
neurons - drug effects - pathology |
4 |
|
neuroprotective agents - pharmacology |
4 |
|
oxidative stress - drug effects |
4 |
|
papilledema - enzymology - pathology - prevention & control |
4 |
|
pyrimidines - therapeutic use |
4 |
|
reperfusion |
4 |
|
reperfusion injury - drug therapy |
4 |
|
reperfusion injury - enzymology - pathology - prevention & control |
4 |
|
retina - cytology - enzymology |
4 |
|
retinal diseases - enzymology - metabolism - pathology |
4 |
|
retinal diseases - enzymology - pathology - prevention & control |
4 |
|
retinal ganglion cells - pathology |
4 |
|
rna, messenger - biosynthesis |
4 |
|
sorbitol dehydrogenase |
4 |
|
stroke - complications - drug therapy - pathology - physiopathology |
4 |
|
stroke - enzymology - metabolism - pathology |
4 |
|
tgfβ1 |
4 |
|
vascular endothelial growth factor a - genetics |
4 |
|
xanthophyll |
4 |
|
412 age-related macular degeneration |
3 |
|
416 amacrine cells |
3 |
|
571 ischemia |
3 |
|
594 microglia |
3 |
|
602 muller cells |
3 |
|
606 neovascularization |
3 |
|
612 neuroprotection |
3 |
|
651 proliferation |
3 |
|
652 proliferative vitreoretinopathy |
3 |
|
696 retinal glia |
3 |
|
697 retinal neovascularization |
3 |
|
698 retinal pigment epithelium |
3 |
|
703 retinopathy of prematurity |
3 |
|
737 transplantation |
3 |
|
age |
3 |
|
age-related macular degeneration |
3 |
|
aldehyde reductase - antagonists & inhibitors - genetics - metabolism |
3 |
|
aldehyde reductase - deficiency |
3 |
|
aldose reductase |
3 |
|
analgesia |
3 |
|
animal models |
3 |
|
animals, newborn |
3 |
|
antioxidant |
3 |
|
antioxidants - pharmacology |
3 |
|
aquaporin |
3 |
|
aquaporin 4 |
3 |
|
aquaporin 4 - genetics - metabolism |
3 |
|
aquaporins - biosynthesis |
3 |
|
astrocytes - drug effects - physiology |
3 |
|
astrocytes - metabolism - ultrastructure |
3 |
|
autoimmune diseases |
3 |
|
autophagy inhibitors |
3 |
|
behavior, animal - physiology |
3 |
|
beta-galactosidase - analysis |
3 |
|
biosafety |
3 |
|
blood pressure - physiology |
3 |
|
blood-brain barrier - physiology |
3 |
|
blood–brain barrier |
3 |
|
blotting, northern - methods |
3 |
|
brain - blood supply - cytology - metabolism - pathology |
3 |
|
brain - blood supply - pathology |
3 |
|
brain - pathology |
3 |
|
brain damage |
3 |
|
brain development |
3 |
|
brain edema - chemically induced - physiopathology |
3 |
|
brain edema - etiology - metabolism |
3 |
|
brain injuries - metabolism - pathology - prevention & control |
3 |
|
brain ischemia - metabolism - pathology - prevention & control |
3 |
|
capillaries - physiology |
3 |
|
carotenoid |
3 |
|
caspase |
3 |
|
caspase 3 - metabolism |
3 |
|
cell damage |
3 |
|
cell death and survival |
3 |
|
cell division |
3 |
|
cell hypoxia |
3 |
|
cell size |
3 |
|
cell survival |
3 |
|
cells, cultured |
3 |
|
coloring agents |
3 |
|
composite hydrogel |
3 |
|
conditional |
3 |
|
cornea stromal scarring |
3 |
|
culture media, serum-free |
3 |
|
cytoprotection - physiology |
3 |
|
cytotoxic edema |
3 |
|
dark agouti rats |
3 |
|
diabetes |
3 |
|
diabetic retinopathy |
3 |
|
diagnosis |
3 |
|
diurnal intraocular pressure fluctuation |
3 |
|
drusen |
3 |
|
ef1α |
3 |
|
eiia-cre |
3 |
|
electrical stimulation therapy |
3 |
|
electroretinographic responses |
3 |
|
electroretinography: non-clinical |
3 |
|
embryo, mammalian |
3 |
|
encapsulated-cell therapy |
3 |
|
endothelin receptor antagonist |
3 |
|
endothelin receptors |
3 |
|
endothelin-1 - biosynthesis |
3 |
|
endothelin-1 - genetics - metabolism |
3 |
|
endothelin-1 - genetics - metabolism - pharmacology |
3 |
|
endothelin-2 - genetics - metabolism |
3 |
|
endothelin-3 |
3 |
|
endothelin-3 - genetics - metabolism |
3 |
|
endothelium, vascular - metabolism - pathology |
3 |
|
enzyme-linked immunosorbent assay |
3 |
|
epithelial wound healing |
3 |
|
epithelium |
3 |
|
et-1-deficient mice |
3 |
|
evans blue |
3 |
|
eye disease |
3 |
|
female |
3 |
|
free radical |
3 |
|
gene expression regulation |
3 |
|
gene expression regulation, developmental - physiology |
3 |
|
genes, reporter - genetics |
3 |
|
gfap |
3 |
|
glial fibrillary acidic protein - genetics - metabolism |
3 |
|
healon |
3 |
|
herpes simplex keratitis |
3 |
|
hippocampus - blood supply - pathology |
3 |
|
homeostasis |
3 |
|
hypoxia/ischemia |
3 |
|
imaging methods (ct, fa, icg, mri, oct, rta, slo, ultrasound) |
3 |
|
imidazolidines - metabolism |
3 |
|
immune homeostasis |
3 |
|
immunity |
3 |
|
in situ hybridization |
3 |
|
in situ hybridization - methods |
3 |
|
in-jury |
3 |
|
infarct |
3 |
|
infarction, middle cerebral artery |
3 |
|
infarction, middle cerebral artery - complications - metabolism - pathology |
3 |
|
infarction, middle cerebral artery - genetics - metabolism - pathology |
3 |
|
infectious keratitis |
3 |
|
inflammation |
3 |
|
inflammatory pain |
3 |
|
integrases - genetics - metabolism |
3 |
|
intestinal microbiota |
3 |
|
iron - metabolism |
3 |
|
knockout mice |
3 |
|
l-iditol 2-dehydrogenase - genetics - metabolism |
3 |
|
l-lactate dehydrogenase - secretion |
3 |
|
lactate dehydrogenase |
3 |
|
lamp1 |
3 |
|
lc3 |
3 |
|
light-triggered drug release |
3 |
|
lutein |
3 |
|
macroautophagy |
3 |
|
male |
3 |
|
management |
3 |
|
mcao |
3 |
|
medulla oblongata - embryology - metabolism |
3 |
|
melatonin |
3 |
|
mice, inbred cba |
3 |
|
mice, knockout |
3 |
|
mice, transgenic |
3 |
|
microbead occlusion |
3 |
|
minimization |
3 |
|
mitochondria |
3 |
|
mouse embryo |
3 |
|
myelination |
3 |
|
myopia |
3 |
|
n-methyl-d-aspartate receptors |
3 |
|
necrosis |
3 |
|
nerve degeneration - genetics - metabolism - pathology |
3 |
|
nervous system diseases - etiology |
3 |
|
neurogenesis |
3 |
|
neurologic deficit |
3 |
|
neurological deficit |
3 |
|
neuroplasticity |
3 |
|
neuroprotective agents |
3 |
|
neurotrauma |
3 |
|
ocular disease |
3 |
|
ocular drug delivery |
3 |
|
ocular stress |
3 |
|
oligodendrocyte |
3 |
|
ophthalmic diseases |
3 |
|
oxygen-induced retinopathy |
3 |
|
peptide elongation factor 1 - genetics |
3 |
|
photoreceptor |
3 |
|
photoreceptor cells, vertebrate - pathology |
3 |
|
polyol pathway |
3 |
|
pons - embryology - metabolism |
3 |
|
pre-emptive |
3 |
|
pregnancy |
3 |
|
prevention |
3 |
|
programmed cell death |
3 |
|
propofol |
3 |
|
rat |
3 |
|
rd10 |
3 |
|
receptor, endothelin a - antagonists & inhibitors |
3 |
|
receptor, endothelin b - antagonists & inhibitors |
3 |
|
receptors, endothelin - genetics - metabolism |
3 |
|
receptors, transferrin - metabolism |
3 |
|
regulated cell death |
3 |
|
reperfusion injury - metabolism - pathology |
3 |
|
reperfusion injury - metabolism - pathology - prevention and control |
3 |
|
respiratory control |
3 |
|
retinal degeneration |
3 |
|
retinal detachment |
3 |
|
retinal detachment - pathology |
3 |
|
retinal diseases - metabolism - pathology - prevention and control |
3 |
|
retinal ganglion cells - drug effects - pathology |
3 |
|
retinal neovascularization - enzymology - pathology - prevention and control |
3 |
|
retinal neuron |
3 |
|
retinal neurons |
3 |
|
retinoblastoma |
3 |
|
retinopathy of prematurity |
3 |
|
retinopathy of prematurity - enzymology - pathology - prevention and control |
3 |
|
reverse transcriptase polymerase chain reaction |
3 |
|
rna, messenger - analysis |
3 |
|
rna, messenger - metabolism |
3 |
|
self-assembly |
3 |
|
severity of illness index |
3 |
|
stem cell |
3 |
|
systematic review |
3 |
|
systemic treatment |
3 |
|
testis - blood supply - metabolism - ultrastructure |
3 |
|
therapy |
3 |
|
topical treatment |
3 |
|
traditional chinese medicine (tcm) |
3 |
|
transferrin - metabolism |
3 |
|
transgenic mice |
3 |
|
trauma |
3 |
|
trigonal small molecules |
3 |
|
two-tiered |
3 |
|
tyrosine - analogs & derivatives - metabolism |
3 |
|
up-regulation |
3 |
|
vasopressin receptor antagonist |
3 |
|
ventrolateral medulla |
3 |
|
viral proteins - genetics - metabolism |
3 |
|
visual cortex |
3 |
|
vitreous substitutes |
3 |
|
water - metabolism |
3 |
|
water intoxication |
3 |
|
481 cornea |
2 |
|
age-related neurodegeneration |
2 |
|
amino acid sequence |
2 |
|
anticoagulants - administration & dosage - pharmacokinetics - therapeutic use |
2 |
|
applications |
2 |
|
biocompatibility |
2 |
|
biomaterials |
2 |
|
blindness |
2 |
|
blood glucose |
2 |
|
brain ischemia - chemically induced - drug therapy |
2 |
|
cattle |
2 |
|
cell differentiation - physiology |
2 |
|
cell encapsulation |
2 |
|
cell proliferation - drug effects |
2 |
|
central nervous system injury |
2 |
|
cerebral blood flow |
2 |
|
clinic |
2 |
|
cytokines |
2 |
|
diabetes mellitus/pathology/physiopathology |
2 |
|
diabetic complications |
2 |
|
diterpenes, abietane |
2 |
|
drug delivery and drug-likeness |
2 |
|
drugs, chinese herbal - administration & dosage - pharmacokinetics - therapeutic use |
2 |
|
endotamponade - methods |
2 |
|
endothelin |
2 |
|
endothelium |
2 |
|
endothelium, corneal - chemistry - cytology - metabolism |
2 |
|
epac |
2 |
|
flavonoid |
2 |
|
fluorocarbons - toxicity |
2 |
|
functional protection |
2 |
|
healthcare |
2 |
|
herbal extracts |
2 |
|
humans |
2 |
|
injections, intraperitoneal |
2 |
|
injury |
2 |
|
knockout |
2 |
|
labiatae |
2 |
|
microcarriers |
2 |
|
middle cerebral artery occlusion |
2 |
|
molecular sequence data |
2 |
|
neovascularization |
2 |
|
neuronal damage |
2 |
|
nfat5 |
2 |
|
oil |
2 |
|
ophthalmologist |
2 |
|
ophthalmology |
2 |
|
peripheral nervous system |
2 |
|
phenanthrenes - administration & dosage - pharmacokinetics - therapeutic use |
2 |
|
phytotherapy |
2 |
|
plant extracts - administration & dosage - pharmacokinetics - therapeutic use |
2 |
|
plant roots |
2 |
|
retinal ganglion cells - drug effects |
2 |
|
retinal pigment epithelium - drug effects |
2 |
|
retinopathy |
2 |
|
salvia miltiorrhiza |
2 |
|
salvia miltiorrhiza bunge |
2 |
|
silicon dioxide - administration and dosage |
2 |
|
silicone oils - administration and dosage - chemistry |
2 |
|
silicone oils - toxicity |
2 |
|
smit |
2 |
|
spectrophotometry |
2 |
|
stem cells - cytology |
2 |
|
tamponade agent |
2 |
|
trabecular meshwork - chemistry - cytology - metabolism |
2 |
|
traditional chinese medicine |
2 |
|
transgenic mouse |
2 |
|
transient retinal ischaemia |
2 |
|
viscosity |
2 |
|
vitreoretinal surgery - methods |
2 |
|
xanthophylls |
2 |
|
561 injection |
1 |
|
748 vascular endothelial growth factor |
1 |
|
763 vitreous |
1 |
|
alternative splicing |
1 |
|
alzheimer disease - metabolism |
1 |
|
alzheimer’s disease |
1 |
|
aminophosphonovalerate |
1 |
|
amyloid beta-peptides - metabolism |
1 |
|
amyloid beta-protein precursor - biosynthesis - immunology |
1 |
|
amyloid beta-protein precursor - genetics - metabolism - secretion |
1 |
|
amyloid beta-protein precursor - metabolism |
1 |
|
amyloid precursor |
1 |
|
amyloid precursor protein secretases |
1 |
|
angiogenesis |
1 |
|
animal cell |
1 |
|
animal experiment |
1 |
|
animal studies |
1 |
|
animal tissue |
1 |
|
anti-vegf |
1 |
|
antibody specificity |
1 |
|
antioxidants |
1 |
|
aplp2 |
1 |
|
aspartic acid - chemistry |
1 |
|
aspartic acid endopeptidases |
1 |
|
autophagy |
1 |
|
axons |
1 |
|
base sequence |
1 |
|
basement membranes |
1 |
|
biological transport |
1 |
|
blood vessel function |
1 |
|
brain - metabolism |
1 |
|
brain - ultrastructure |
1 |
|
brain neoplasm |
1 |
|
carotenoids |
1 |
|
cell compartmentation |
1 |
|
cell fractionation |
1 |
|
cell line |
1 |
|
cell membrane |
1 |
|
cell polarity |
1 |
|
cell surface |
1 |
|
cell-based therapy |
1 |
|
cerebellar macroneurons |
1 |
|
cerebellum - metabolism |
1 |
|
cerebral cortex - cytology - metabolism |
1 |
|
cerebral edema |
1 |
|
chondroitin sulfates - metabolism |
1 |
|
clathrin - metabolism |
1 |
|
clathrin-coated vesicles |
1 |
|
clinical trials |
1 |
|
coated vesicles - metabolism |
1 |
|
cobalt chloride |
1 |
|
collagen–alginate composite hydrogel |
1 |
|
cross reactions |
1 |
|
cytoplasmic granules - metabolism - ultrastructure |
1 |
|
diabetic retinopathy - chemically induced - genetics - pathology |
1 |
|
dna primers |
1 |
|
dna, complementary - isolation & purification - metabolism |
1 |
|
dogs |
1 |
|
encapsulated cell therapy |
1 |
|
endocrinology medical sciences |
1 |
|
endocytosis |
1 |
|
endopeptidases - metabolism |
1 |
|
epigenetic modification |
1 |
|
gastroenterology medical sciences |
1 |
|
gene expression |
1 |
|
gene library |
1 |
|
gene therapy |
1 |
|
gliosis |
1 |
|
glur-b |
1 |
|
glutamate |
1 |
|
glycosaminoglycans - metabolism |
1 |
|
golgi apparatus - metabolism |
1 |
|
golgi apparatus - metabolism - ultrastructure |
1 |
|
hedera helix |
1 |
|
hederagenin |
1 |
|
huntingtin |
1 |
|
huntington disease - genetics |
1 |
|
hydrogen peroxide |
1 |
|
hydrolysis |
1 |
|
hyperglycemia |
1 |
|
immunocytochemistry |
1 |
|
ischemia-reperfusion injury |
1 |
|
kidney - cytology - enzymology - metabolism |
1 |
|
kinetics |
1 |
|
laser treatment |
1 |
|
macula |
1 |
|
macular degeneration |
1 |
|
medical sciences |
1 |
|
membrane proteins - metabolism |
1 |
|
metabolism |
1 |
|
microscopy, immunoelectron |
1 |
|
mouse models |
1 |
|
mutation |
1 |
|
nanoengineered materials |
1 |
|
needleless |
1 |
|
neovascularization, pathologic - pathology |
1 |
|
nerve tissue proteins |
1 |
|
nerve tissue proteins - biosynthesis |
1 |
|
nerve tissue proteins - metabolism |
1 |
|
neurons - metabolism |
1 |
|
neurovascular unit |
1 |
|
nmda receptor |
1 |
|
noninvasive |
1 |
|
nuclear proteins |
1 |
|
nurses and nursing |
1 |
|
ocular delivery |
1 |
|
oligodeoxyribonucleotides |
1 |
|
organ specificity |
1 |
|
parkinson’s disease |
1 |
|
polymerase chain reaction |
1 |
|
presynaptic terminals - metabolism |
1 |
|
pretreatment |
1 |
|
prophylaxis |
1 |
|
protein processing, post-translational |
1 |
|
protein trafficking |
1 |
|
proteins - analysis - chemistry - genetics |
1 |
|
rats |
1 |
|
rats - embryology |
1 |
|
recombinant proteins - metabolism |
1 |
|
repetitive sequences, nucleic acid |
1 |
|
retinal disease |
1 |
|
rna probes |
1 |
|
rna, messenger - analysis - metabolism |
1 |
|
scaffolds |
1 |
|
sequence homology, amino acid |
1 |
|
subcellular fractions - enzymology |
1 |
|
synaptic vesicle recycling |
1 |
|
synaptic vesicles - physiology |
1 |
|
tissue distribution |
1 |
|
tissue engineering |
1 |
|
tissue regeneration |
1 |
|
transcription, genetic |
1 |
|
transfection |
1 |
|
traumatic brain injury |
1 |
|
treatment |
1 |
|
vascular development |
1 |
|
vascular endothelial growth factor |
1 |
|
vascular pathology |
1 |
|
vascular protection |
1 |
|
wound dressing |
1 |
|
α-hederin |
1 |
|
α-synuclein |
1 |
